Literature DB >> 3823184

Disorganization of the rat activity rhythm by chronic treatment with methamphetamine.

K Honma, S Honma, T Hiroshige.   

Abstract

Remarkable changes in the circadian activity rhythm of rats were observed when they were chronically treated with methamphetamine dissolved in drinking water. The circadian rhythm was phase-delayed with respect to the light-dark (LD) cycle, and showed signs of relative coordination. In some rats, the circadian organization was disturbed and two activity components appeared, with one component free-running and the other entrained by the LD cycle. After methamphetamine withdrawal, these changes disappeared rapidly but there were transient periods of 2-3 days before establishment of a stable entrainment to the LD cycle. The changes in the circadian rhythm persisted even in constant darkness (DD). The period around 24 hr in DD was significantly shorter during methamphetamine treatment than after the drug withdrawal. These results indicate that neither alteration of the sensitivity to light nor lengthening of the intrinsic period is involved in the methamphetamine induced disorganization of the circadian rhythm. Possible mechanisms are discussed in terms of a multi-oscillatory system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3823184     DOI: 10.1016/0031-9384(86)90265-9

Source DB:  PubMed          Journal:  Physiol Behav        ISSN: 0031-9384


  21 in total

1.  The methamphetamine-sensitive circadian oscillator does not employ canonical clock genes.

Authors:  Jennifer A Mohawk; Matthew L Baer; Michael Menaker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-09       Impact factor: 11.205

2.  Period determination in the food-entrainable and methamphetamine-sensitive circadian oscillator(s).

Authors:  Julie S Pendergast; Gisele A Oda; Kevin D Niswender; Shin Yamazaki
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-13       Impact factor: 11.205

3.  The effect of methamphetamine on serotonin and its metabolite in the suprachiasmatic nucleus: a microdialysis study.

Authors:  N Ozaki; D Nakahara; Y Kasahara; T Nagatsu
Journal:  J Neural Transm Gen Sect       Date:  1991

4.  Learned motivation drives circadian physiology in the absence of the master circadian clock.

Authors:  Oliver Rawashdeh; Shannon J Clough; Randall L Hudson; Margarita L Dubocovich
Journal:  FASEB J       Date:  2016-10-12       Impact factor: 5.191

Review 5.  Circadian dysfunction may be a key component of the non-motor symptoms of Parkinson's disease: insights from a transgenic mouse model.

Authors:  L David Willison; Takashi Kudo; Dawn H Loh; Dika Kuljis; Christopher S Colwell
Journal:  Exp Neurol       Date:  2013-01-24       Impact factor: 5.330

6.  The Clock Gene Rev-Erbα Regulates Methamphetamine Actions on Circadian Timekeeping in the Mouse Brain.

Authors:  Nora L Salaberry; Maria Mateo; Jorge Mendoza
Journal:  Mol Neurobiol       Date:  2016-09-01       Impact factor: 5.590

7.  Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.

Authors:  P E Paulson; D M Camp; T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

8.  Effects of neonatal methamphetamine and thioperamide exposure on spatial memory retention and circadian activity later in life.

Authors:  Emily Eastwood; Charles N Allen; Jacob Raber
Journal:  Behav Brain Res       Date:  2012-02-11       Impact factor: 3.332

9.  The complex relationship between the light-entrainable and methamphetamine-sensitive circadian oscillators: evidence from behavioral studies of Period-mutant mice.

Authors:  Julie S Pendergast; Kevin D Niswender; Shin Yamazaki
Journal:  Eur J Neurosci       Date:  2013-07-22       Impact factor: 3.386

Review 10.  Circadian rhythms and addiction: mechanistic insights and future directions.

Authors:  Ryan W Logan; Wilbur P Williams; Colleen A McClung
Journal:  Behav Neurosci       Date:  2014-04-14       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.